Jing He1,2, Wenhui Song3, Jinlong Yang3,4, Sen Lu5, Yuan Yuan5, Junfu Guo5, Jie Zhang2, Kai Ye5, Fan Yang5, Fangfang Long3, Zhiyu Peng5, Haijing Yu4, Le Cheng3,6, Baosheng Zhu1,2. 1. Yunnan Provincial Key Laboratory For Birth Defects and Genetic Diseases, The First People's Hospital of Yunnan Province, Kunming, China. 2. Medical School of Kunming University in Science and Technology, Kunming, China. 3. BGI-Yunnan, BGI-Shenzhen, Kunming, China. 4. College of Life Sciences, Yunnan University, Kunming, China. 5. BGI-Shenzhen, Shenzhen, China. 6. College of Clinical Medicine, College of Basic Medical Sciences, Dali University, Dali, China.
Abstract
PURPOSE: Thalassemia is one of the most common monogenic diseases in southwestern China, especially among the Dai ethnic group. Here, we explore the feasibility of a next-generation sequencing (NGS) screening method specifically for the Dai people. METHODS: Blood samples were obtained from Dai people for premarital screening. Double-blind, parallel hemoglobinopathy screening was conducted using both traditional hematological methods (red cell indexes and hemoglobin electrophoresis, then DNA sequencing) and an NGS approach. RESULTS: Among 951 tested individuals, we found a thalassemia carrier rate of 49.5% (471/951) using the NGS screen, in contrast to 22.0% (209/951) found using traditional methods. Almost 74.8% (217/290) of α-thalassemia carriers and 30.5% (25/82) of composite α- and β-thalassemia carriers were missed by traditional screens. The proportion of such α- and β-thalassemia carriers among the Dai people is 8.6% (82/951). For β-thalassemia carriers, the high ratio (66/99) of CD26 mutations may suggest a correlation between CD26 and the environmental adaption of the Dai people. CONCLUSIONS: Methodological comparisons demonstrate the superiority of NGS for both sensitivity and specificity, provide a comprehensive assessment of thalassemia screening strategies, and indicate that NGS is a competitive screening method, especially among populations with a high prevalence of disease.Genet Med advance online publication 26 January 2017.
PURPOSE: Thalassemia is one of the most common monogenic diseases in southwestern China, especially among the Dai ethnic group. Here, we explore the feasibility of a next-generation sequencing (NGS) screening method specifically for the Dai people. METHODS: Blood samples were obtained from Dai people for premarital screening. Double-blind, parallel hemoglobinopathy screening was conducted using both traditional hematological methods (red cell indexes and hemoglobin electrophoresis, then DNA sequencing) and an NGS approach. RESULTS: Among 951 tested individuals, we found a thalassemia carrier rate of 49.5% (471/951) using the NGS screen, in contrast to 22.0% (209/951) found using traditional methods. Almost 74.8% (217/290) of α-thalassemia carriers and 30.5% (25/82) of composite α- and β-thalassemia carriers were missed by traditional screens. The proportion of such α- and β-thalassemia carriers among the Dai people is 8.6% (82/951). For β-thalassemia carriers, the high ratio (66/99) of CD26 mutations may suggest a correlation between CD26 and the environmental adaption of the Dai people. CONCLUSIONS: Methodological comparisons demonstrate the superiority of NGS for both sensitivity and specificity, provide a comprehensive assessment of thalassemia screening strategies, and indicate that NGS is a competitive screening method, especially among populations with a high prevalence of disease.Genet Med advance online publication 26 January 2017.
Authors: F Xiong; M Sun; X Zhang; R Cai; Y Zhou; J Lou; L Zeng; Q Sun; Q Xiao; X Shang; X Wei; T Zhang; P Chen; X Xu Journal: Clin Genet Date: 2010-04-19 Impact factor: 4.438
Authors: Thessalia Papasavva; Wilfred F J van Ijcken; Christel E M Kockx; Mirjam C G N van den Hout; Petros Kountouris; Loukas Kythreotis; Eleni Kalogirou; Frank G Grosveld; Marina Kleanthous Journal: Eur J Hum Genet Date: 2013-04-10 Impact factor: 4.246
Authors: Bao-sheng Zhu; Jing He; Jie Zhang; Xiao-hong Zeng; Jie Su; Xiang-hu Xu; Su-yun Li; Hong Chen; Yin-hong Zhang Journal: Zhonghua Fu Chan Ke Za Zhi Date: 2012-02
Authors: E S Edison; R V Shaji; S G Devi; A Moses; A Viswabandhya; V Mathews; B George; A Srivastava; M Chandy Journal: Clin Genet Date: 2008-02-20 Impact factor: 4.438